Skip to content

The Post-operative Analgesia of the Virtual Reality Using a Mirror Therapy After Total Knee Arthroplasty

The Post-operative Analgesia of the Virtual Reality Using a Mirror Therapy After Total Knee Arthroplasty: Prospective, Single-blind, Parallel Group, Randomized, Single Cohort Clinical Trial of Efficacy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01979718
Enrollment
60
Registered
2013-11-08
Start date
2013-11-30
Completion date
2016-06-30
Last updated
2016-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nociceptive Pain, Osteoarthritis, Knee, Virtual Reality

Brief summary

It was well known that the mirror therapy could decrease pain of upper-limb amputated patients. The mirror therapy is known to make a plastic change some parts of the brain perceiving the painful body part and modulating its signal by feedback of visual information mirrored with the corresponding contra-lateral normal parts. In this study, post-operative analgesic efficiency of the virtual reality using a mirror therapy after total knee arthroplasty will be evaluated. This clinical trial will be performed in the form of prospective, single-blind (i.e. assessor-blind), parallel group, randomized (allocation ratio 1:1), single cohort.

Interventions

DEVICEMirrored Virtual reality

Patients are required to look at the images of both lower extremities ranged from the perineal area to the foot. Virtual reality system records in real-time method both lower extremities. Following the validity assessement mirrored image of the surgeried lower extremity is re-formed using the virtusal reality system flipping the image of lower extremity not-surgeried and being calibration for the symmetricity.

Sponsors

Ulsan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients who were transferred to RM after unilateral TKA

Exclusion criteria

* patients cannot freely move the contralat. leg d/t neurologic or musculoskeletal problems * patients are not enough clear to indicate VAS * patients cannot look at the virtual reality monitor d/t visual problem * refusal of the participation

Design outcomes

Primary

MeasureTime frameDescription
6 minute walk testshortly after the 1st and 2nd session (5 days) intervention, and after 6 weeks after interventionThe distance walked at a self-selected speed along a 40 cm corridor in 6 min. The distance was measured in meters, and more the meters better the result. A walking aid was used if needed.

Secondary

MeasureTime frameDescription
Visual analogue scale (VAS) while movingshortly after the 1st and 2nd session (5 days) intervention, and after 6 weeks after interventionchecking the VAS while resting
Active ROM of flexion and extension on the kneeshortly after the 1st and 2nd session (5 days) intervention, and after 6 weeks after intervention
Tridol consumption per weekafter the 1st and 2nd session (5 days) intervention
Visual analogue scale (VAS) while restingshortly after the 1st and 2nd session (5 days) intervention, and after 6 weeks after interventionchecking the VAS while resting
Graded ambulation distancesshortly after the 1st and 2nd session (5 days) intervention, and after 6 weeks after interventionGrade 1: able to ambulate ≤5 feet Grade 2: able to ambulate \>5 feet but \<10 feet Grade 3: able to ambulate \>10 feet but \<30 feet Grade 4: able to ambulate ≥30 feet
Timed-stands testshortly after the 1st and 2nd session (5 days) intervention, and after 6 weeks after interventionThe patients were asked to rise from and sit down on a chair with a height of 45 cm, 10 times and as quickly as possible, without using the armrests. The time spent was recorded.
Side effectsafter the 1st and 2nd session (5 days) intervention
WOMAC indexshortly after the 1st and 2nd session (5 days) intervention, and after 6 weeks after intervention

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026